Corindus rebranded as Siemens Healthineers Endovascular Robotics

Corindus, a Siemens Healthineers Company, announced it has been rebranded to Siemens Healthineers Endovascular Robotics, a dedicated business within the Advanced Therapies area of Siemens Healthineers. The aim of the Endovascular Robotics business is to advance interventions with robotics and change the way that care is delivered through innovations that enhance physician technique and bring precision to interventional procedures, stated the company in its press release.

All Corindus channels, including the company website and social media profiles, officially shut down on December 16, 2022. All the materials previously shared via the Corindus website can now be accessed on the Siemens Healthineers website in the Endovascular Robotics section.

According to the company, this brand unification is the final step of the company integration process that commenced in 2019 with the acquisition of Corindus by Siemens Healthineers. Siemens announced the acquisition in August 2019 and Corindus announced stockholder approval of the transaction in October 2019.

The company further noted that as the dedicated Endovascular Robotics business of Siemens Healthineers, it has access to the resources of a leading global medical technology company that will allow it to continue to develop innovative image-guided robotic solutions. The company will continue to offer the CorPath GRX system to support endovascular procedures while developing other technologies to provide specialized medical care.

Wayne Markowitz, Worldwide Executive Vice President of Siemens Healthineers and Head of Endovascular Robotics, commented in the press release, “The completion of our brand evolution marks the final step to becoming a united company and we remain focused on pioneering breakthroughs for everyone, everywhere. Our flagship product, the CorPath GRX system, is designed to support endovascular interventions, and we look forward to working with our customers as Siemens Healthineers Endovascular Robotics while fueling our vision to connect more patients to advanced care.”

Dr. John A. Kaufman
Previous post

Cook Medical Appoints John A. Kaufman as Chief Medical Officer

Next post

Stryker’s Target Tetra detachable coil for treating small aneurysms cleared by FDA

Vein Therapy News

Vein Therapy News